← back to search

David W. Johnson

Mitsubishi Chemical (Germany) · DE
Area of research
Nephrology · Transplantation
Research interest
Research interests include Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Renal Transplantation Outcomes and Treatments, and Acute Kidney Injury Research.
h-index
134
citations
82,453
works
2,063
NIH funding
primary concept
email

Recent publications

Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox
Nephrology Dialysis Transplantation 2025cited by 2position: middledoi
Frequency of therapy alerts during the first 30 days of automated peritoneal dialysis and its relationship to time on treatment
Peritoneal Dialysis International 2025cited by 1position: middledoi
An update on the global disparities in kidney disease burden and care across world countries and regions
The Lancet Global Health 2024cited by 429position: middledoi
Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
Kidney International Supplements 2024cited by 31position: middledoi
Assisted peritoneal dialysis: Position paper for the ISPD
Peritoneal Dialysis International 2024cited by 27position: middledoi
Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy
Kidney International Reports 2024cited by 22position: middledoi
Capacity for the management of kidney failure in the International Society of Nephrology Africa region: report from the 2023 ISN Global Kidney Atlas (ISN-GKHA)
Kidney International Supplements 2024cited by 17position: middledoi
A global assessment of kidney care workforce
Nephrology Dialysis Transplantation 2024cited by 13position: lastdoi
Experiences of Social Isolation and Loneliness in Chronic Kidney Disease
Clinical Journal of the American Society of Nephrology 2024cited by 12position: middledoi
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection
Kidney International 2024cited by 12position: middledoi
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
Kidney International Supplements 2024cited by 10position: middledoi
Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas
BMC Nephrology 2024cited by 10position: lastdoi
Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap
Nephrology 2024cited by 8position: middledoi
A global snapshot on health systems capacity for detection, monitoring, and management of acute kidney injury: A multinational study from the ISN-GKHA
PLOS Global Public Health 2024cited by 4position: middledoi
Uptake and Outcomes of Peritoneal Dialysis among Aboriginal and Torres Strait Islander People: Analysis of Registry Data
Kidney International Reports 2024cited by 4position: lastdoi
#1060 Prevalence and adverse outcomes of hypokalemia and the role of potassium supplementation in patients receiving peritoneal dialysis
Nephrology Dialysis Transplantation 2024cited by 0position: middledoi
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine 2023cited by 144position: middledoi
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial
The Lancet 2023cited by 74position: middledoi
Synbiotics, prebiotics and probiotics for people with chronic kidney disease
Cochrane Database of Systematic Reviews 2023cited by 46position: middledoi
Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial
Trials 2023cited by 38position: middledoi
National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas
PLOS Global Public Health 2023cited by 36position: lastdoi
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Cochrane Database of Systematic Reviews 2023cited by 25position: middledoi
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol
BMJ Open 2023cited by 6position: middledoi
Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis
Nephrology Dialysis Transplantation 2023cited by 5position: middledoi
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
Peritoneal Dialysis International 2022cited by 633position: lastdoi
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
JAMA 2022cited by 317position: middledoi
Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy
Kidney International Reports 2022cited by 34position: middledoi
Perspectives of Patients, Nurses, and Nephrologists About Electronic Symptom Monitoring With Feedback in Hemodialysis Care
American Journal of Kidney Diseases 2022cited by 23position: middledoi
Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study
Kidney International Reports 2022cited by 18position: middledoi
Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis
International Journal of Antimicrobial Agents 2022cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jonathan C. Craig · Murdoch Children's Research Institute41 papers (2012–2024)Suetonia C. Palmer · University of Otago25 papers (2013–2024)Giovanni FM Strippoli · The University of Sydney24 papers (2013–2023)Carmel M. Hawley · Australasian Society for Infectious Diseases24 papers (2012–2023)Allison Tong · Brigham and Women's Hospital20 papers (2012–2022)Neil Boudville · The University of Western Australia17 papers (2012–2025)Sunil V. Badve · Emory University17 papers (2012–2019)Marcello Tonelli · Institute of Public Health Zadar17 papers (2013–2024)Germaine Wong · Children's Hospital at Westmead14 papers (2012–2023)Kevan R. Polkinghorne · Monash Medical Centre13 papers (2012–2023)Yeoungjee Cho · Indiana University School of Medicine13 papers (2013–2024)Stephen P. McDonald · Sheffield Hallam University12 papers (2012–2025)Philip A. Clayton · South Australia Pathology12 papers (2012–2023)Armando Teixeira-Pinto · The University of Sydney11 papers (2016–2023)David C.H. Harris · Westmead Institute for Medical Research10 papers (2012–2022)Elaine M. Pascoe · Indiana University School of Medicine10 papers (2013–2024)Marinella Ruospo · The University of Sydney10 papers (2013–2021)Ikechi G. Okpechi · University of Alberta10 papers (2017–2024)Vivekanand Jha · Rajamangala Institute of kidney disease9 papers (2019–2024) · 9 papers (2016–2025)